21 May 2009
Cytometric analysis of CD4+CD25+FOXP3+ regulatory t cells in peripheral blood of patients undergoing kideny transplantation
M Karczewski, J Karczewski, M Głyda, K WiktorowiczAnn Transplant 2009; 14(1): 37-37 :: ID: 880333
Abstract
Background: CD4 CD25 Foxp3 regulatory T cells (Tregs) represent 5-10% of peripheral CD4 T cells and have been suggested to prevent acute graft rejection (AR). Our project was aimed to investigate the relation between the level of pre-transplant and post-transplant peripheral Tregs and the development of AR episodes in patients after kidney transplantation.
Material/Methods: The project included 44 patients undergoing kidney
transplantation. During the six-months period following the transplantation AR
was diagnosed in 11 patients. Peripheral blood samples were collected 1 day before and 10 days after the transplantation and cytometrically tested for concentrations of Tregs.
Results: The pre-transplant analysis showed significantly lower levels of peripheral Tregs in AR patients vs. control. A lower level of Tregs was also observed in NONAR patients vs. control, however, it was still higher than in the AR group. The 10-day post-transplantation analysis showed a similar pattern,
however, a significant increase in the concentration of Tregs in NONAR patients was observed, whereas no change was recorded in AR patients.
Conclusions: Lower pre-transplant levels of peripheral Tregs were found in both groups, AR and NONAR vs. control group. The deficiency of Tregs in patients with end-stage renal failure might be due to the long-term inflammatory processes adversely affecting the peripheral regulatory mechanisms, however significantly lower levels of Tregs observed in AR patients might also be related to genetic predispositions. Our observation suggests that the size and possibly the functionality of Tregs in AR group was not sufficient to successfully control the immune response after kidney transplantation leading to AR.
Keywords: Immunosuppression, Kidney Transplantation, Tissue typing
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






